Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Interleukin-5, eosinophils, and disease.

Sanderson CJ.

Blood. 1992 Jun 15;79(12):3101-9. Review. No abstract available.

2.

Airway hyperresponsiveness: first eosinophils and then neuropeptides.

Kraneveld AD, Folkerts G, Van Oosterhout AJ, Nijkamp FP.

Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):517-27. Review.

PMID:
9637348
3.

Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma.

Menzies-Gow A, Robinson DS.

Curr Opin Pulm Med. 2002 Jan;8(1):33-8. Review.

PMID:
11753121
4.

Cellular and molecular regulation of eosinophil trafficking to the lung.

Hogan SP, Mould AW, Young JM, Rothenberg ME, Ramsay AJ, Matthaei K, Young IG, Foster PS.

Immunol Cell Biol. 1998 Oct;76(5):454-60.

PMID:
9797467
5.

Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.

Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD.

Mol Med. 1996 May;2(3):334-48.

6.

IL-5-induced airway eosinophilia--the key to asthma?

Hamelmann E, Gelfand EW.

Immunol Rev. 2001 Feb;179:182-91. Review.

PMID:
11292022
7.

Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.

Mould AW, Matthaei KI, Young IG, Foster PS.

J Clin Invest. 1997 Mar 1;99(5):1064-71.

8.

Elemental signals regulating eosinophil accumulation in the lung.

Foster PS, Mould AW, Yang M, Mackenzie J, Mattes J, Hogan SP, Mahalingam S, Mckenzie AN, Rothenberg ME, Young IG, Matthaei KI, Webb DC.

Immunol Rev. 2001 Feb;179:173-81. Review.

PMID:
11292021
9.

Eosinophils and the lung.

Bertorelli G, Pesci A.

Monaldi Arch Chest Dis. 1994 Jun;49(3):221-6. Review.

PMID:
8087119
10.

Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy.

Weltman JK, Karim AS.

Allergy Asthma Proc. 1998 Sep-Oct;19(5):257-61. Review.

PMID:
9801738
11.

Gastrointestinal eosinophils in health and disease.

Rothenberg ME, Mishra A, Brandt EB, Hogan SP.

Adv Immunol. 2001;78:291-328. Review. No abstract available.

PMID:
11432207
12.

[Evidence of the harmful effects of eosinophils in bronchial asthma].

Mehić B, Konjicija A, Zutić H, Lukić Z.

Plucne Bolesti. 1990 Jan-Jun;42(1-2):104-6. Croatian.

PMID:
2217619
13.

Eosinophil trafficking to sites of allergic inflammation.

Broide D, Sriramarao P.

Immunol Rev. 2001 Feb;179:163-72. Review.

PMID:
11292020
14.

Eosinophils negatively regulate eosinophilopoiesis by decreasing IL-5 levels.

Enokihara H, Koike T, Nakamura Y, Yamashiro K, Tsuruoka N, Saito K, Furusawa S.

Int Arch Allergy Immunol. 1996;111 Suppl 1:2-4.

PMID:
8906102
15.

Cytokines as targets for the inhibition of eosinophilic inflammation.

Hogan SP, Foster PS.

Pharmacol Ther. 1997;74(3):259-83. Review.

PMID:
9352584
16.

Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.

Xu J, Jiang F, Nayeri F, Zetterström O.

Respir Med. 2007 Jul;101(7):1447-54. Epub 2007 Mar 26.

17.

Regulation of eosinophilopoiesis in a murine model of asthma.

Hogan MB, Weissman DN, Hubbs AF, Gibson LF, Piktel D, Landreth KS.

J Immunol. 2003 Sep 1;171(5):2644-51.

18.

IL-5 priming of eosinophil function in asthma.

Sampson AP.

Clin Exp Allergy. 2001 Apr;31(4):513-7. No abstract available.

PMID:
11359415
19.

Chemokines and IL-5: major players of eosinophil recruitment in asthma.

Teran LM.

Clin Exp Allergy. 1999 Mar;29(3):287-90. No abstract available.

PMID:
10202332
20.

[Allergic inflammation and eosinophils: trials, tribulations and enigma of IL-5, eosinophils and asthma].

Takatsu K.

Arerugi. 2005 Feb;54(2):48-52. Review. Japanese. No abstract available.

PMID:
15864017

Supplemental Content

Support Center